Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Renal Cell 73Neoplasm Metastasis 30Kidney Neoplasms 26Neoplasms 19Breast Neoplasms 14Prostatic Neoplasms 12Urinary Bladder Neoplasms 10Melanoma 9Gastrointestinal Stromal Tumors 9Brain Neoplasms 9Glioblastoma 8Sarcoma 7Carcinoma, Non-Small-Cell Lung 7Liver Neoplasms 6Carcinoma, Hepatocellular 6Recurrence 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Esophageal Neoplasms 5Colorectal Neoplasms 5Thyroid Neoplasms 4Solid Tumors 4Osteosarcoma 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Adenocarcinoma 4Uveal Melanoma 3Thymoma 3Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

AZD 6244 9Lovastatin 5Deoxycholic Acid 4trametinib 3Lasers, Solid-State 3mirdametinib 2fludarabine 2Transcranial Direct Current Stimulation 2Sirolimus 2Polidocanol 2Magnetic Resonance Imaging 2Lasers 2Lamotrigine 2Inhalation 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1peginterferon alfa-2b 1gadolinium compound P760 1fludarabine phosphate 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1X-Rays 1Vitamin D 1Vincristine 1Vinblastine 1Temozolomide 1Surgical Procedures, Operative 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurofibromatosis 1 × Sunitinib × Clear all
NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
50 enrolled 6 charts
CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡